Transcranial Magnetic Stimulation Clinical Trial
Official title:
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
Verified date | July 2023 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with an alcohol use disorder (AUD).
Status | Active, not recruiting |
Enrollment | 10 |
Est. completion date | November 2023 |
Est. primary completion date | May 17, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 70 Years |
Eligibility | Inclusion Criteria: - The study will be open to male and females, regardless of race and ethnic origin, 21-70 years of age, who are in active treatment for an AUD at the VAPAHCS, Foundations of Recovery. - Participants must meet Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for AUD, and alcohol is self-identified as the primary substance of misuse. - Able to read, verbalize understanding, and voluntarily sign the Informed Consent Form prior to participation in study procedures in English. - Participants will be accepted if taking medications specifically for the treatment of major depressive disorders, cigarette smoking, or for other psychiatric conditions as long as the medications are not documented to lower seizure threshold - it would be clinically contraindicated to require participants to discontinue such medications for research. rTMS is safely administered to individuals who are taking psychotropic medications that do not lower seizure threshold. - Participants will be abstinent from alcohol and non-prescribed substances for at least 7 consecutive days prior to rTMS to ensure no participant is experiencing active acute withdrawal. Exclusion Criteria: Psychiatric: - Current diagnosis of Schizophrenia Spectrum Disorders and Bipolar Disorders; - Current moderate-severe substance use disorder other than alcohol, tobacco, or marijuana, based on DSM-5 diagnostic criteria; - Active current suicidal intent or plan (patients with a previous clinical flag for risk for suicide will be required to have an established safety plan involving their primary psychiatrist and the treatment team before entering the clinical trial, any form of previous rTMS or electroconvulsive treatment) Biomedical: Including, but not limited to: - Uncontrolled thyroid disease, - Unstable congestive heart failure, - Angina - Other severe cardiac illness as defined by treatment regimen changes in the prior 3 months - Cerebrovascular accident, cancer if < 1 year since end of treatment; - Unstable diabetes - COPD requiring oxygen supplementation - Alzheimer's disease - Parkinson's disease - Any biomedical implants with ferromagnetic content, neurostimulation devices, cardiac pacemakers or any magnetic resonance contraindications; - Traumatic brain injury with self-reported or observed loss of consciousness > 30 minutes, any primary or traumatically induced seizure disorder, and alcohol-related seizure(s) in the past 30 days. General: - Lack of fluency in English; - Wechsler Adult Reading Test below the 7th percentile (i.e., moderate or greater impairment in estimated general intelligence); - Females who are pregnant or actively attempting pregnancy; - Conservative exclusion for magnetic resonance research, current use of any medication or substance that is documented to lower seizure threshold or has been identified as a contraindication for rTMS treatment. |
Country | Name | City | State |
---|---|---|---|
United States | VA Palo Alto Health Care System | Palo Alto | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University | VA Palo Alto Health Care System |
United States,
Harel M, Perini I, Kampe R, Alyagon U, Shalev H, Besser I, Sommer WH, Heilig M, Zangen A. Repetitive Transcranial Magnetic Stimulation in Alcohol Dependence: A Randomized, Double-Blind, Sham-Controlled Proof-of-Concept Trial Targeting the Medial Prefrontal and Anterior Cingulate Cortices. Biol Psychiatry. 2022 Jun 15;91(12):1061-1069. doi: 10.1016/j.biopsych.2021.11.020. Epub 2021 Dec 6. — View Citation
Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010 Jan;35(1):217-38. doi: 10.1038/npp.2009.110. Erratum In: Neuropsychopharmacology. 2010 Mar;35(4):1051. — View Citation
Peters SK, Dunlop K, Downar J. Cortico-Striatal-Thalamic Loop Circuits of the Salience Network: A Central Pathway in Psychiatric Disease and Treatment. Front Syst Neurosci. 2016 Dec 27;10:104. doi: 10.3389/fnsys.2016.00104. eCollection 2016. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Relapse to alcohol 6months after treatment | Six months after completing the intervention, participants will be contacted to determine self-reported relapse status. Participants will complete brief standardized measures of alcohol and substance use, Alcohol Timeline Followback (TLFB) and the Brief Addiction Monitor (BAM) questionnaire. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05973019 -
rTMS Improves Functions in Spinocerebellar Ataxia
|
N/A | |
Recruiting |
NCT06193278 -
Individual Neuromodulation for PDS
|
N/A | |
Completed |
NCT05074524 -
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
|
N/A | |
Recruiting |
NCT05889117 -
Brain Stimulation for Concussion
|
N/A | |
Recruiting |
NCT03974659 -
Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients
|
N/A | |
Recruiting |
NCT05613686 -
Theta Burst Stimulation for Motor Recovery
|
N/A | |
Completed |
NCT04014491 -
The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome
|
N/A | |
Recruiting |
NCT05914038 -
Individualized rTMS for Motor Recovery in Stroke Patients
|
N/A | |
Recruiting |
NCT06084455 -
TMS-evoked Potentials During Aerobic Exercise
|
N/A | |
Completed |
NCT05566444 -
TMS-evoked Potentials During Heat Pain
|
N/A | |
Enrolling by invitation |
NCT04313530 -
TMS Treatment in Multiple System Atrophy With Fatigue
|
N/A | |
Completed |
NCT04209309 -
Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal
|
N/A | |
Terminated |
NCT04486222 -
Accelerated Bilateral rTMS on Geriatric Depression
|
N/A | |
Recruiting |
NCT05192759 -
Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait
|
N/A | |
Recruiting |
NCT05467657 -
Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke
|
N/A | |
Recruiting |
NCT05896332 -
rTMS in Older Adults With MCI and AUD
|
Phase 1 | |
Recruiting |
NCT04727177 -
Precision-targeted Transcranial Magnetic Stimulation in the Treatment of Primary Dystonia
|
Early Phase 1 | |
Recruiting |
NCT04906603 -
Theta Burst Stimulation for Headaches After Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT03590327 -
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05843240 -
Effects of Repetitive Transcranial Magnetic Stimulation on Cerebral Autoregulation in Patients With Acute Ischemic Stroke
|
N/A |